Antiangiogenic Cancer Therapy by Darren W. Davis, Roy S. Herbst, and James L. Abbruzzese

Description

The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. This work promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis will lead to optimal therapeutic strategies and positive clinical results. It compiles the work of leading experts to explore angiogenesis inhibitors under clinical investigation, as well as early agents used in preclinical studies. It discusses the unique aspects of targeting and inhibiting angiogenesis and the challenges associated with clinical development of angiogenesis inhibitors including trial design and surrogate marker endpoints The chapters are organized to allow readers easy access to the fundamental concepts of angiogenesis and information on the complexities associated with targeting angiogenesis for specific types of cancer.

Disclaimer:
Contents of this page are indexed from the Internet. All actions are under your responsability. Email us to report illegal contents or external links and we'll remove them immediately.

Please check the description for download links if any or do a search to find alternative books.

Can't Download?
Please search mirrors if you can't find download links for "Antiangiogenic Cancer Therapy by Darren W. Davis, Roy S. Herbst, and James L. Abbruzzese" in "Description" and someone else may update the links. Check the comments when back to find any updates.

Search Mirrors
Maybe some mirror pages will be helpful, search this book at top of this page or click here to find more info.

1. Ebooks list page : 2900
2. Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development)
3. Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development)
4. Antiangiogenic Cancer Therapy
5. Antiangiogenic Cancer Therapy
6. Antiangiogenic Cancer Therapy (US$199.95)
7. Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
8. Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
9. EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development)
10. Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
11. Combination Cancer Therapy Modulators and Potentiators (Cancer Drug Discovery and Development)
12. Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)
13. Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
14. Deoxynucleoside Analogs in Cancer Therapy (Cancer Drug Discovery and Development)
15. Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development) by: Val R. Adams
16. Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)